The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH/ISH 2016 | The standardization of flow cytometry
Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses the standardization of flow cytometry in acute myeloid leukemia (AML). Currently there is a lack of harmonization in ideas of pathologists working with AML. However, Dr Roboz outlines the European Leukemia Net’s attempts to create a standardization of techniques to create a worldwide effort to understand what residual detectable populations mean and how much they need to be reduce in order to demonstrate a new therapy’s efficacy. Recorded at the 2016 Annual Meeting of the British Society of Haematology (BSH) and International Society of Hematology (ISH), in Glasgow, Scotland.
